Citation classics in neuro-oncology

Assessment of historical trends and scientific progress

Laureen D. Hachem, Seyed Alireza Mansouri, Kyle Juraschka, Shervin Taslimi, Farhad Pirouzmand, Gelareh Zadeh

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Background. Citation classics represent the highest cited works in a field and are often regarded as the most influential literature. Analyzing thematic trends in citation classics across eras enables recognition of important historical advances within a field. We present the first analysis of the citation classics in neuro-oncology. Methods. The Web of Science database was searched using terms relevant to "neuro-oncology." Articles with >400 citations were identified and the top 100 cited articles were evaluated. Results. The top 100 neuro-oncology citation classics consisted of 43 clinical studies (17 retrospective, 10 prospective, 16 randomized trials), 43 laboratory investigations, 8 reviews/meta-analyses, and 6 guidelines/consensus statements. Articles were classified into 4 themes: 13 pertained to tumor classification, 37 to tumor pathogenesis/clinical presentation, 6 to imaging, 44 to therapy (15 chemotherapy, 10 radiotherapy, 5 surgery, 14 new agents). Gliomas were the most common tumor type examined, with 70 articles. There was a significant increase in the number of citation classics in the late 1990s, which was paralleled by an increase in studies examining tumor pathogenesis, chemotherapy, and new agents along with laboratory and randomized studies. Conclusions. The majority of citation classics in neuro-oncology are related to gliomas and pertain to tumor pathogenesis and treatment. The rise in citation classics in recent years investigating tumor biology, new treatment agents, and chemotherapeutics may reflect increasing scientific interest in nonsurgical treatments for CNS tumors and the need for fundamental investigations into disease processes.

Original languageEnglish (US)
Pages (from-to)1158-1172
Number of pages15
JournalNeuro-oncology
Volume19
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Neoplasms
Glioma
Drug Therapy
Therapeutics
Meta-Analysis
Radiotherapy
Databases
Guidelines

All Science Journal Classification (ASJC) codes

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Hachem, Laureen D. ; Mansouri, Seyed Alireza ; Juraschka, Kyle ; Taslimi, Shervin ; Pirouzmand, Farhad ; Zadeh, Gelareh. / Citation classics in neuro-oncology : Assessment of historical trends and scientific progress. In: Neuro-oncology. 2017 ; Vol. 19, No. 9. pp. 1158-1172.
@article{1732b0651385487d87454b9853a27c41,
title = "Citation classics in neuro-oncology: Assessment of historical trends and scientific progress",
abstract = "Background. Citation classics represent the highest cited works in a field and are often regarded as the most influential literature. Analyzing thematic trends in citation classics across eras enables recognition of important historical advances within a field. We present the first analysis of the citation classics in neuro-oncology. Methods. The Web of Science database was searched using terms relevant to {"}neuro-oncology.{"} Articles with >400 citations were identified and the top 100 cited articles were evaluated. Results. The top 100 neuro-oncology citation classics consisted of 43 clinical studies (17 retrospective, 10 prospective, 16 randomized trials), 43 laboratory investigations, 8 reviews/meta-analyses, and 6 guidelines/consensus statements. Articles were classified into 4 themes: 13 pertained to tumor classification, 37 to tumor pathogenesis/clinical presentation, 6 to imaging, 44 to therapy (15 chemotherapy, 10 radiotherapy, 5 surgery, 14 new agents). Gliomas were the most common tumor type examined, with 70 articles. There was a significant increase in the number of citation classics in the late 1990s, which was paralleled by an increase in studies examining tumor pathogenesis, chemotherapy, and new agents along with laboratory and randomized studies. Conclusions. The majority of citation classics in neuro-oncology are related to gliomas and pertain to tumor pathogenesis and treatment. The rise in citation classics in recent years investigating tumor biology, new treatment agents, and chemotherapeutics may reflect increasing scientific interest in nonsurgical treatments for CNS tumors and the need for fundamental investigations into disease processes.",
author = "Hachem, {Laureen D.} and Mansouri, {Seyed Alireza} and Kyle Juraschka and Shervin Taslimi and Farhad Pirouzmand and Gelareh Zadeh",
year = "2017",
month = "9",
day = "1",
doi = "10.1093/neuonc/nox053",
language = "English (US)",
volume = "19",
pages = "1158--1172",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "9",

}

Hachem, LD, Mansouri, SA, Juraschka, K, Taslimi, S, Pirouzmand, F & Zadeh, G 2017, 'Citation classics in neuro-oncology: Assessment of historical trends and scientific progress', Neuro-oncology, vol. 19, no. 9, pp. 1158-1172. https://doi.org/10.1093/neuonc/nox053

Citation classics in neuro-oncology : Assessment of historical trends and scientific progress. / Hachem, Laureen D.; Mansouri, Seyed Alireza; Juraschka, Kyle; Taslimi, Shervin; Pirouzmand, Farhad; Zadeh, Gelareh.

In: Neuro-oncology, Vol. 19, No. 9, 01.09.2017, p. 1158-1172.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Citation classics in neuro-oncology

T2 - Assessment of historical trends and scientific progress

AU - Hachem, Laureen D.

AU - Mansouri, Seyed Alireza

AU - Juraschka, Kyle

AU - Taslimi, Shervin

AU - Pirouzmand, Farhad

AU - Zadeh, Gelareh

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Background. Citation classics represent the highest cited works in a field and are often regarded as the most influential literature. Analyzing thematic trends in citation classics across eras enables recognition of important historical advances within a field. We present the first analysis of the citation classics in neuro-oncology. Methods. The Web of Science database was searched using terms relevant to "neuro-oncology." Articles with >400 citations were identified and the top 100 cited articles were evaluated. Results. The top 100 neuro-oncology citation classics consisted of 43 clinical studies (17 retrospective, 10 prospective, 16 randomized trials), 43 laboratory investigations, 8 reviews/meta-analyses, and 6 guidelines/consensus statements. Articles were classified into 4 themes: 13 pertained to tumor classification, 37 to tumor pathogenesis/clinical presentation, 6 to imaging, 44 to therapy (15 chemotherapy, 10 radiotherapy, 5 surgery, 14 new agents). Gliomas were the most common tumor type examined, with 70 articles. There was a significant increase in the number of citation classics in the late 1990s, which was paralleled by an increase in studies examining tumor pathogenesis, chemotherapy, and new agents along with laboratory and randomized studies. Conclusions. The majority of citation classics in neuro-oncology are related to gliomas and pertain to tumor pathogenesis and treatment. The rise in citation classics in recent years investigating tumor biology, new treatment agents, and chemotherapeutics may reflect increasing scientific interest in nonsurgical treatments for CNS tumors and the need for fundamental investigations into disease processes.

AB - Background. Citation classics represent the highest cited works in a field and are often regarded as the most influential literature. Analyzing thematic trends in citation classics across eras enables recognition of important historical advances within a field. We present the first analysis of the citation classics in neuro-oncology. Methods. The Web of Science database was searched using terms relevant to "neuro-oncology." Articles with >400 citations were identified and the top 100 cited articles were evaluated. Results. The top 100 neuro-oncology citation classics consisted of 43 clinical studies (17 retrospective, 10 prospective, 16 randomized trials), 43 laboratory investigations, 8 reviews/meta-analyses, and 6 guidelines/consensus statements. Articles were classified into 4 themes: 13 pertained to tumor classification, 37 to tumor pathogenesis/clinical presentation, 6 to imaging, 44 to therapy (15 chemotherapy, 10 radiotherapy, 5 surgery, 14 new agents). Gliomas were the most common tumor type examined, with 70 articles. There was a significant increase in the number of citation classics in the late 1990s, which was paralleled by an increase in studies examining tumor pathogenesis, chemotherapy, and new agents along with laboratory and randomized studies. Conclusions. The majority of citation classics in neuro-oncology are related to gliomas and pertain to tumor pathogenesis and treatment. The rise in citation classics in recent years investigating tumor biology, new treatment agents, and chemotherapeutics may reflect increasing scientific interest in nonsurgical treatments for CNS tumors and the need for fundamental investigations into disease processes.

UR - http://www.scopus.com/inward/record.url?scp=85031800436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031800436&partnerID=8YFLogxK

U2 - 10.1093/neuonc/nox053

DO - 10.1093/neuonc/nox053

M3 - Review article

VL - 19

SP - 1158

EP - 1172

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 9

ER -